Cite
HARVARD Citation
Hummelink, K. et al. (2019). Cell-free DNA in the supernatant of pleural effusion can be used to detect driver and resistance mutations, and can guide tyrosine kinase inhibitor treatment decisions. ERJ open research. 5 (1), p. . [Online].